These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6931315)

  • 21. Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease.
    Brusa L; Petta F; Pisani A; Moschella V; Iani C; Stanzione P; Miano R; Finazzi-Agrò E
    Neurology; 2007 May; 68(18):1455-9. PubMed ID: 17470746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment.
    Palleschi G; Pastore AL; Stocchi F; Bova G; Inghilleri M; Sigala S; Carbone A
    Clin Neuropharmacol; 2006; 29(4):220-9. PubMed ID: 16855424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urodynamic study in the differential diagnosis between multiple system atrophy and Parkinson's disease.
    Stocchi F; Barbato L; Carbone A; Fabbrini G; Ruggieri S; Bonamartini A; Baffigo G; Agnoli A
    Adv Neurol; 1993; 60():434-7. PubMed ID: 8420168
    [No Abstract]   [Full Text] [Related]  

  • 24. Neurogenic bladder in Parkinson's disease.
    Greenberg M; Gordon HL; McCutchen JJ
    South Med J; 1972 Apr; 65(4):446-8. PubMed ID: 5028401
    [No Abstract]   [Full Text] [Related]  

  • 25. Lower urinary tract symptoms and bladder control in advanced Parkinson's disease: effects of deep brain stimulation in the subthalamic nucleus.
    Winge K; Nielsen KK; Stimpel H; Lokkegaard A; Jensen SR; Werdelin L
    Mov Disord; 2007 Jan; 22(2):220-5. PubMed ID: 17133504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute urinary retention in two patients after subthalamic nucleus deep brain stimulation (STN-DBS) for the treatment of advanced Parkinson's disease.
    Fritsche HM; Ganzer R; Schlaier J; Wieland WF; Brawanski A; Lange M
    Mov Disord; 2009 Jul; 24(10):1553-4. PubMed ID: 19441136
    [No Abstract]   [Full Text] [Related]  

  • 27. Urinary dysfunction in Parkinson's disease: a review.
    Blackett H; Walker R; Wood B
    Parkinsonism Relat Disord; 2009 Feb; 15(2):81-7. PubMed ID: 18474447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship between weight loss and dysphagia in patients with Parkinson's disease].
    Nozaki S; Saito T; Matsumura T; Miyai I; Kang J
    Rinsho Shinkeigaku; 1999 Oct; 39(10):1010-4. PubMed ID: 10655760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bladder dysfunction in Parkinsonism: mechanisms, prevalence, symptoms, and management.
    Winge K; Fowler CJ
    Mov Disord; 2006 Jun; 21(6):737-45. PubMed ID: 16570299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Voiding dysfunction in Parkinson's disease.
    Sotolongo JR
    Semin Neurol; 1988; 8(2):166-9. PubMed ID: 3055123
    [No Abstract]   [Full Text] [Related]  

  • 31. Urinary disorders in Parkinson's disease and multiple system atrophy.
    Fowler CJ
    Funct Neurol; 2001; 16(3):277-82. PubMed ID: 11769873
    [No Abstract]   [Full Text] [Related]  

  • 32. A diagnostic challenge of Parkinson's disease: intractable hiccups.
    Yardimci N; Benli S; Zileli T
    Parkinsonism Relat Disord; 2008; 14(5):446-7. PubMed ID: 18329942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of dopaminergic treatment on bladder function in Parkinson's disease.
    Winge K; Werdelin LM; Nielsen KK; Stimpel H
    Neurourol Urodyn; 2004; 23(7):689-96. PubMed ID: 15382192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Perioperative management of a patient with Parkinson's disease with intravenous infusion of levodopa].
    Mizuno J; Kato S; Watada M; Morita S
    Masui; 2009 Oct; 58(10):1286-9. PubMed ID: 19860235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Symptoms and duration of the prodromal phase in Parkinson's disease.
    Gonera EG; van't Hof M; Berger HJ; van Weel C; Horstink MW
    Mov Disord; 1997 Nov; 12(6):871-6. PubMed ID: 9399209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metatarsal fracture as a consequence of foot dystonia in Parkinson's disease.
    McDade E; Weiner WJ; Shulman LM
    Parkinsonism Relat Disord; 2008; 14(4):353-5. PubMed ID: 18457984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Severe chronic pain with allodynia in Parkinson's disease: a case report].
    Ito S; Asahina M; Asahina M; Oki T; Hattori T
    Rinsho Shinkeigaku; 2001; 41(2-3):147-9. PubMed ID: 11481860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary dysfunction in Parkinson's disease.
    Singer C
    Clin Neurosci; 1998; 5(2):78-86. PubMed ID: 10785832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Urinary symptoms and urodynamic findings in Parkinson's disease].
    Barrero R; Mir P; Cayuela A; Campoy P; Pena JM; Alberca R
    Neurologia; 2007 Mar; 22(2):93-8. PubMed ID: 17323234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on the neurology of Parkinson's disease.
    Fowler CJ
    Neurourol Urodyn; 2007; 26(1):103-9. PubMed ID: 17080417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.